Clinical trial
Cholestanol in Humans
NCT00018694 · US Department of Veterans Affairs, U.S. Fed · Withdrawn
Key facts
| NCT number | NCT00018694 |
|---|---|
| Title | Cholestanol in Humans |
| Official title | Biologic Significance of Cholestanol in Man |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Cerebrotendinous Xanthomatosis |
| Intervention type | Drug |
| Interventions | Chenodeoxycholic Acid |
| Enrollment | 0 |
| Start date | Oct 1, 1999 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jul 5, 2001 |
| Last update posted | Oct 14, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: